An IL28B Genotype-Based Clinical Prediction Model for Treatment of Chronic Hepatitis C

BACKGROUND: Genetic variation in IL28B and other factors are associated with sustained virological response (SVR) after pegylated-interferon/ribavirin treatment for chronic hepatitis C (CHC). Using data from the HALT-C Trial, we developed a model to predict a patient's probability of SVR based...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Thomas R., Everhart, James E., Morgan, Timothy R., Lok, Anna S., Chung, Raymond T., Shao, Yongwu, Shiffman, Mitchell L., Dotrang, Myhanh, Sninsky, John J., Bonkovsky, Herbert L., Pfeiffer, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132753/
https://www.ncbi.nlm.nih.gov/pubmed/21760886
http://dx.doi.org/10.1371/journal.pone.0020904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132753/
https://www.ncbi.nlm.nih.gov/pubmed/21760886
http://dx.doi.org/10.1371/journal.pone.0020904

Ejemplares similares